Hematological complications of chronic HCV infection and its treatment

Serum hepcidin levels in patients with chronic hepatitis C

Diabetic chronic HCV patients and their response to interferon therapy

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Serum ferritin and reduced glutathione concentrations in chronic hepatitis C patients treated with interferon-alpha

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

Serum levels of AFP after interferon-based therapy with ribavirin for genotype 4 chronic HCV patients

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin